EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Source-tracking ESBL-producing bacteria at the maternity ward of Mulago hospital, Uganda

Richard Mayanja, Adrian Muwonge iD, Dickson Aruhomukama, Fred Ashaba Katabazi, Mudarshiru Bbuye, Edgar Kigozi, Annettee Nakimuli, Musa Sekikubo, Christine Florence Najjuka, David Patrick Kateete iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0286955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Richard Mayanja und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda. Hauptthemen laut MEDLINE: Escherichia coli, Anti-Bacterial Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Escherichia coli , Klebsiella pneumoniae and Enterobacter (EKE) are the leading cause of mortality and morbidity in neonates in Africa. The management of EKE infections remains challenging given the global emergence of carbapenem resistance in Gram-negative bacteria. This study aimed to investigate the source of EKE organisms for neonates in the maternity environment of a national referral hospital in Uganda, by examining the phenotypic and molecular characteristics of isolates from mothers, neonates, and maternity ward.

Methods

From August 2015 to August 2016, we conducted a cross-sectional study of pregnant women admitted for elective surgical delivery at Mulago hospital in Kampala, Uganda; we sampled (nose, armpit, groin) 137 pregnant women and their newborns (n = 137), as well as health workers (n = 67) and inanimate objects (n = 70 –beds, ventilator tubes, sinks, toilets, door-handles) in the maternity ward. Samples (swabs) were cultured for growth of EKE bacteria and isolates phenotypically/molecularly investigated for antibiotic sensitivity, as well as β-lactamase and carbapenemase activity. To infer relationships among the EKE isolates, spatial cluster analysis of phenotypic and genotypic susceptibility characteristics was done using the Ridom server.

Results

Gram-negative bacteria were isolated from 21 mothers (15%), 15 neonates (11%), 2 health workers (3%), and 13 inanimate objects (19%); a total of 131 Gram-negative isolates were identified of which 104 were EKE bacteria i.e., 23 (22%) E . coli , 50 (48%) K . pneumoniae , and 31 (30%) Enterobacter . Carbapenems were the most effective antibiotics as 89% (93/104) of the isolates were susceptible to meropenem; however, multidrug resistance was prevalent i.e., 61% (63/104). Furthermore, carbapenemase production and carbapenemase gene prevalence were low; 10% (10/104) and 6% (6/104), respectively. Extended spectrum β-lactamase (ESBL) production occurred in 37 (36%) isolates though 61 (59%) carried ESBL-encoding genes, mainly bla CTX-M (93%, 57/61) implying that bla CTX-M is the ideal gene for tracking ESBL-mediated resistance at Mulago. Additionally, spatial cluster analysis revealed isolates from mothers, new-borns, health workers, and environment with similar phenotypic/genotypic characteristics, suggesting transmission of multidrug-resistant EKE to new-borns.

Conclusion

Our study shows evidence of transmission of drug resistant EKE bacteria in the maternity ward of Mulago hospital, and the dynamics in the ward are more likely to be responsible for transmission but not individual mother characteristics. The high prevalence of drug resistance genes highlights the need for more effective infection prevention/control measures and antimicrobial stewardship programs to reduce spread of drug-resistant bacteria in the hospital, and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliAnti-Bacterial AgentsPregnancyHumansFemaleInfant, NewbornUgandaCross-Sectional Studiesbeta-LactamasesKlebsiella pneumoniaeHospitalsEnterobacterGram-Negative BacteriaMicrobial Sensitivity Tests

Substanzen

Anti-Bacterial Agentsbeta-Lactamases

Autor:innen und Institutionen

  • Department of Medical Microbiology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
  • Department of Immunology and Molecular Biology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
  • The Roslin Institute, College of Medicine and Veterinary Studies, The Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, United Kingdom.
  • Department of Obstetrics and Gynaecology, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.

ORCID-Profile: Adrian Muwonge, David Patrick Kateete

Förderung

  • Medical Research Council

Zitieren

APA

Mayanja, R., Muwonge, A., Aruhomukama, D., Katabazi, F. A., Bbuye, M., Kigozi, E., Nakimuli, A., Sekikubo, M., Najjuka, C. F., & Kateete, D. P. (2023). Source-tracking ESBL-producing bacteria at the maternity ward of Mulago hospital, Uganda. PLOS ONE. https://doi.org/10.1371/journal.pone.0286955

Vancouver

Mayanja R, Muwonge A, Aruhomukama D, Katabazi FA, Bbuye M, Kigozi E, et al. Source-tracking ESBL-producing bacteria at the maternity ward of Mulago hospital, Uganda. PLOS ONE. 2023. doi:10.1371/journal.pone.0286955

BibTeX
@article{Mayanja2023,
  author = {Mayanja, Richard and Muwonge, Adrian and Aruhomukama, Dickson and Katabazi, Fred Ashaba and Bbuye, Mudarshiru and Kigozi, Edgar and Nakimuli, Annettee and Sekikubo, Musa and Najjuka, Christine Florence and Kateete, David Patrick},
  title = {Source-tracking ESBL-producing bacteria at the maternity ward of Mulago hospital, Uganda},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0286955}
}
Kostenlos starten →